US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 471.120
  • -4.860-1.02%
Close Nov 1 16:00 ET
  • 463.762
  • -7.358-1.56%
Post 20:02 ET
121.60BMarket Cap-237939P/E (TTM)

Vertex Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vertex Pharmaceuticals Q3 2024 Estimates Date

Currency：USDNov 4, 2024

Estimate YoY
Revenue
2.69B
+8.33%
EPS
3.63
-8.55%
Analyst Rating
Buy

Nov 3, 2024

Vertex Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 26 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.746B--
Nov 4, 20242024/Q3-- / 2.690B--
Aug 1, 20242024/Q22.646B / 2.665B--
--2024/Q12.691B / 2.580B--
Feb 5, 20242023/Q42.518B / 2.515B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.746B--
Nov 4, 20242024/Q3-- / 2.690B--
Aug 1, 20242024/Q22.646B / 2.665B--
--2024/Q12.691B / 2.580B--
Feb 5, 20242023/Q42.518B / 2.515B--

Unlock Free Earnings Estimates

Vertex Pharmaceuticals Earnings Reports

  • Vertex Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 2 16:06 ET

  • Vertex Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 7 16:50 ET

  • Vertex Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 15 16:20 ET

  • Vertex Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 16:16 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 3, 2024

    Buy

    • Buy

      64.00%

    • Hold

      32.00%

    • Sell

      4.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Gene Editing
    Gene Editing
    Intraday+0.75%